Rezultati - Milind Javle
- Showing 1 - 20 results of 83
- Go to Next Page
-
1
Molecular profiling of biliary tract cancer: a target rich disease od Apurva Jain, Milind Javle
Izdano 2016Revisão -
2
-
3
-
4
Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer od Milind Javle, Elizabeth Smyth, Ian Chau
Izdano 2014Revisão -
5
Systemic therapy for gallbladder cancer od Milind Javle, Haitao Zhao, Ghassan K. Abou‐Alfa
Izdano 2019Revisão -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference od Gonzalo Sapisochín, Milind Javle, Jan Lerut, Masayuki Ohtsuka, R. Mark Ghobrial, Taizo Hibi, Nancy Man Kwan, Julie K. Heimbach
Izdano 2020Revisão -
14
-
15
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma od Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Izdano 2018Artigo -
16
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer od Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, Tove Buhl, Rune Smaaland, Herish Garresori, Milind Javle, Nils Glenjen, B.K. Abelseth, Bjørnar Gilje, Oddmund Nordgård
Izdano 2018Artigo -
17
Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance od Daniel H. Ahn, Milind Javle, Chul Ahn, Apurva Jain, Sameh Mikhail, Anne M. Noonan, Christina Wu, Rachna T. Shroff, James L. Chen, Tanios Bekaii‐Saab
Izdano 2016Artigo -
18
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma od Nawapol Kunkeaw, Sung Ho Jeon, K Lee, Betty H. Johnson, S. Tanasanvimon, Milind Javle, Chawalit Pairojkul, Yaovalux Chamgramol, Wipaporn Wongfieng, Bin Gong, Chanvit Leelayuwat, Y S Lee
Izdano 2012Artigo -
19
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... od Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman
Izdano 2016Artigo -
20
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants od Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Oncology
Biology
Cancer research
Pancreatic cancer
Gastroenterology
Chemotherapy
Gene
Genetics
Gemcitabine
Colorectal cancer
Mutation
Surgery
Pathology
Adenocarcinoma
Breast cancer
Biochemistry
Clinical trial
Adverse effect
Cohort
Confidence interval
Radiation therapy
Gallbladder cancer
Intrahepatic Cholangiocarcinoma
Receptor
Targeted therapy
CDKN2A
Clinical endpoint